APH.Lライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (4 5月 2024 @ 00:35):

Stats
本日の出来高	6.19M
平均出来高	1.03M
時価総額	178.87M
EPS	£0 ( 2024-04-09 )
Last Dividend	£1.184 ( 2023-06-22 )
Next Dividend	£0 ( N/A )
P/E	-33.10
ATR14	£0.114 (0.34%)

ボリューム相関

長: -0.18 (neutral)

短: 0.15 (neutral)

Signal:(59.282) Neutral

Alliance Pharma PLC 相関

10 最も正の相関
RCN.L	0.919
XUEB.L	0.905
BIRG.L	0.905
AIBG.L	0.902
FOG.L	0.896
EBQ.L	0.885
NUM.L	0.883
DTY.L	0.881
EMAU.L	0.871
CLIN.L	0.867

10 最も負の相関
TEP.L	-0.906
3NIS.L	-0.896
LNGA.L	-0.885
GFIN.L	-0.884
INHC.L	-0.882
PTRO.L	-0.882
GIF.L	-0.882
BIDS.L	-0.878
ECHO.L	-0.872
PUR.L	-0.871

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Alliance Pharma PLC 相関 - 通貨/商品

0.81
( strong )

0.57
( weak )

-0.66
( moderate negative )

0.86
( strong )

0.29
( neutral )

-0.69
( moderate negative )

Alliance Pharma PLC 財務諸表

Annual	2022
収益:	£167.42M
総利益:	£101.68M (60.74 %)
EPS:	£0.00170

FY	2022
収益:	£167.42M
総利益:	£101.68M (60.74 %)
EPS:	£0.00170

FY	2021
収益:	£163.21M
総利益:	£109.45M (67.06 %)
EPS:	£0.0137

FY	2020
収益:	£129.80M
総利益:	£82.82M (63.80 %)
EPS:	£0.0154

Financial Reports:

No articles found.

Alliance Pharma PLC Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
£0 (N/A)	£0.592 (N/A)	£0 (N/A)	£1.184 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)

Alliance Pharma PLC Dividend Information - Dividend Knight

Dividend Sustainability Score: 6.61 - average (87.25%) | Divividend Growth Potential Score: 1.442 - No dividend expected

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	£0.0700	2009-12-02
Last Dividend	£1.184	2023-06-22
Next Dividend	£0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	28	--
Total Paid Out	£15.63	--
Avg. Dividend % Per Year	1.27%	--
Score	3	--
Div. Sustainability Score	6.61
Div.Growth Potential Score	1.442
Div. Directional Score	4.03	--

Next Divdend (Est)
(2024-10-14)

£1.255 Estimate 3.64 %

Dividend Stability

0.29 Very Poor

Dividend Score

3.00

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield
2009	£0.0700	2.33%
2010	£0.400	1.48%
2011	£0.650	2.11%
2012	£0.775	2.51%
2013	£0.853	2.67%
2014	£0.938	2.32%
2015	£1.033	2.79%
2016	£1.137	2.65%
2017	£1.250	2.75%
2018	£1.375	2.04%
2019	£1.513	2.30%
2020	£0.536	0.63%
2021	£2.20	2.50%
2022	£1.720	1.57%
2023	£1.184	2.17%
2024	£0	0.00%

Dividend Commentary

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for LSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SPX.L	Dividend Knight	2023-10-12	Semi-Annually	32	0.67%
JARA.L	Dividend Knight	2023-08-03	Quarterly	5	2.54%
BSIF.L	Dividend Knight	2023-08-17	Quarterly	11	3.73%
PMI.L	Dividend King	2023-07-06	Semi-Annually	8	4.24%
FRAN.L	Dividend Knight	2023-09-14	Semi-Annually	8	0.75%
ABD.L	Dividend Knight	2023-08-10	Semi-Annually	35	0.96%
THRL.L	Dividend King	2023-08-10	Quarterly	12	3.80%
LIO.L	Dividend Royal	2023-06-29	Semi-Annually	24	261.80%
CLDN.L	Dividend Knight	2023-06-29	Semi-Annually	21	1.73%
RICO.L	Dividend Knight	2023-09-28	Semi-Annually	17	1.55%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.0415	1.500	-0.830	-1.245	[0 - 0.5]
returnOnAssetsTTM	-0.0137	1.200	-0.458	-0.550	[0 - 0.3]
returnOnEquityTTM	-0.0250	1.500	-1.389	-2.08	[0.1 - 1]
payoutRatioTTM	-1.315	-1.000	-10.00	10.00	[0 - 1]
currentRatioTTM	1.931	0.800	5.35	4.28	[1 - 3]
quickRatioTTM	1.333	0.800	6.86	5.49	[0.8 - 2.5]
cashRatioTTM	0.533	1.500	8.15	10.00	[0.2 - 2]
debtRatioTTM	0.242	-1.500	5.96	-8.94	[0 - 0.6]
interestCoverageTTM	3.05	1.000	9.98	9.98	[3 - 30]
operatingCashFlowPerShareTTM	0.0402	2.00	9.99	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.0397	2.00	9.98	10.00	[0 - 20]
debtEquityRatioTTM	0.449	-1.500	8.20	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.516	1.000	4.74	4.74	[0.2 - 0.8]
operatingProfitMarginTTM	0.144	1.000	9.13	9.13	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.174	1.000	-0.143	-0.143	[0.2 - 2]
assetTurnoverTTM	0.331	0.800	-1.127	-0.901	[0.5 - 2]
Total Score				6.61

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-25.32	1.000	-2.66	0	[1 - 100]
returnOnEquityTTM	-0.0250	2.50	-0.893	-2.08	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.0397	2.00	9.99	10.00	[0 - 30]
dividendYielPercentageTTM	3.58	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.0402	2.00	9.99	10.00	[0 - 30]
payoutRatioTTM	-1.315	1.500	-10.00	10.00	[0 - 1]
pegRatioTTM	-47.87	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.128	1.000	9.31	0	[0.1 - 0.5]
Total Score				1.442

Alliance Pharma PLC

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. It holds the marketing rights of approximately 80 consumer healthcare and prescription medicine products. The company also offers medical devices, food supplements, and cosmetics. Alliance Pharma plc provides its products under the Aloclair, Anbesol, Asthon and Parsons, Atopiclair, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen brand names. The company was founded in 1996 and is headquartered in Chippenham, the United Kingdom.